Table 1.
Baseline demographics summary of study participants
Particulars | Placebo (n = 35), mean ± SE | VE (n = 37), mean ± SE |
---|---|---|
Age (years) | 33.57 ± 1.06 | 35.35 ± 0.92 |
Male, n (%) | 16 (45.71%) | 15 (40.54%) |
Female, n (%) | 19 (54.29%) | 22 (59.46%) |
BMI (kg/m2) | 24.96 ± 0.51 | 25.48 ± 0.52 |
Pittsburgh sleep quality index (PSQI) | 11.43 ± 0.22 | 11.89 ± 0.20 |
Sleep latency (min) by WA | 74.26 ± 5.24 | 89.39 ± 8.20 |
Actual sleep time (min) by WA | 339.80 ± 6.40 | 306.09 ± 7.61 |
Sleep efficiency (%) by WA | 72.87 ± 1.15 | 66.40 ± 1.67 |
Beck anxiety inventory (BAI) | 11.57 ± 0.24 | 11.30 ± 0.22 |
Epworth sleepiness scale (ESS) | 8.74 ± 0.32 | 8.65 ± 0.25 |
VAS (feeling of waking up refreshed) | 7.29 ± 0.13 | 6.98 ± 0.15 |
Percentages are based on the number of subjects in the specified treatment
SE standard error, WA wrist actigraphy